- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00295295
Vibration Intervention to Improve Bone and Muscle in Children With Cerebral Palsy
Mechanical Intervention in Children With Cerebral Palsy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The extent of bone mass built up during childhood and adolescence is the most important determinant of osteoporosis later in life. Some disabled children, such as those with cerebral palsy, are particularly vulnerable to low bone mass accumulation due to decreased mobility and weight-bearing. These children also have poor muscle strength and control, which limits function and contributes to the lack of mechanical stimulation needed to build bone mass. The most common treatment for these children is physical therapy, which is time- and labor-intensive and may not be adequately available to them. Whole body vibration has shown promise as an alternative method for stimulating increases in bone mass and improvements in muscle. The purpose of this study is to evaluate the effects of high frequency, low magnitude vibration on bone and muscle in children with cerebral palsy. This intervention may be useful as a noninvasive, nonpharmacological treatment for low bone mass and poor muscle function in these children.
This study will last 1 year. All participants will visit the hospital 3 times, at study entry and Months 6 and 12. At each visit, height and weight will be measured, muscle strength and balance will be tested, and bones and muscles in the spine and lower leg will be imaged with computed tomography (CT), a special x-ray machine. Participants will be randomly assigned to one of two groups. For this study, all participants will be asked to stand for 10 minutes every day for 1 year. For Group 1, a vibrating platform will be used for the 10-minute standing sessions during the first half of the study but not during the second half of the study. For Group 2, this will be reversed and the vibrating platform will not be used during the first half of the study but will be used during the second half of the study.
Study Type
Enrollment
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
California
-
Los Angeles, California, United States, 90027
- Children's Hospital Los Angeles
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Diagnosis of cerebral palsy
- Low vertebral bone density
- Able to stand for 10 minutes with handheld support
- Parent or guardian willing to provide informed consent
Exclusion Criteria:
- Surgery, casting, or receipt of botulinum toxin in the 12 months prior to study entry
- Planned surgery, casting, or receipt of botulinum toxin in the 12 months after study entry
- Metal rods or plates in tibia or lumbar spine
- Severe scoliosis (greater than 20 degrees) or bowing of tibia
- Medical condition other than cerebral palsy affecting bone or muscle
- Require corticosteroids or seizure medication (phenytoin)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Vibration
High frequency, low magnitude vibration at 30 Hz, 10 min/day using vibrating platform from Juvent Medical Inc.
|
High frequency, low magnitude vibration at 30 Hz, 10 min/day using vibrating platform from Juvent Medical Inc.
|
|
Active Comparator: Standing
Standing 10 min/day
|
Standing 10 min/day
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Vertebral bone density
Time Frame: Measured at Month 12
|
Measured at Month 12
|
|
Tibia bone density
Time Frame: Measured at Month 12
|
Measured at Month 12
|
|
Tibia cross-sectional area
Time Frame: Measured at Month 12
|
Measured at Month 12
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Calf muscle strength
Time Frame: Measured at Month 12
|
Measured at Month 12
|
|
|
Balance test
Time Frame: Measured at Month 12
|
Clinical balance test used by California Children's Services, Los Angeles County Medical Therapy Units
|
Measured at Month 12
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Tishya A.L. Wren, PhD, Children's Orthopaedic Center, Children's Hospital Los Angeles, and Departments of Orthopaedics and Radiology, Keck School of Medicine, Department of Biomedical Engineering, School of Engineering, University of Southern California
Study record dates
Study Major Dates
Study Start
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1R21AR051564 (U.S. NIH Grant/Contract)
- R21AR051564 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.